Article

Establishment of human post-vaccination SARS-CoV-2 standard reference sera

2022-01-25

Abstract excerpt

<h4>ABSTRACT</h4> As SARS-CoV-2 variants emerge, there is a critical need to understand the effectiveness of serum elicited by different SARS-CoV-2 vaccines. A reference reagent comprised of post-vaccination sera from recipients of different vaccines allows evaluation of in vitro variant neutralization, and provides a reference for comparing assay results across laboratories. We prepared and pooled >1 L serum from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8ecba750-6340-5c8b-baec-4abac4f9f06a
DOI: 10.1101/2022.01.24.22269773

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Establishment of human post-vaccination SARS-CoV-2 standard reference seraDOI 10.1101/2022.01.24.22269773Read

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 seraSemantic proximity Read

IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity Read

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.SSemantic proximity Read

First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineSemantic proximity Read

SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-Reactive IgG and Unequal Strain-Specific Neutralizing Antibodies in Naïve and Previously Infected RecipientsSemantic proximity Read

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and - experienced subjectsSemantic proximity Read

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 VariantsSemantic proximity Read

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.Semantic proximity Read

STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE networkSemantic proximity Read

Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic testSemantic proximity Read